Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 190 participants.
Also called NCT01868646
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose supportive care
- Phase
- Phase 4
- Enrolled
- 190 participants
- Sponsor
- Materia Medica Holding
- Registry
-
NCT01868646
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Russia
- Registry status
- Completed
Technical summary
Registry record NCT01868646. Randomized; quadruple masking; primary purpose supportive care. Start 2013-05-07 (actual); primary completion 2016-06-15 (actual). Results posted on 2019-03-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus
- Condition
- Type II Diabetes Mellitus
- Intervention (Drug)
- Subetta
- Intervention (Drug)
- Placebo
- Lead sponsor
- Materia Medica Holding
Record details
- Record id
cardio:ct-nct01868646- Content hash
b65939b4b3b6092d9e1eaa2dbdbef20b9e875ae4603957e14dda9d481e677fb1